Researchers evaluated intratracheal MSCs as an approach to treat an hyperoxia-induced bronchopulmonary dysplasia animal model and compared the therapeutic effects between amniotic fluid-, umbilical cord- and bone marrow-MSCs.
[Journal of Cellular and Molecular Medicine]
6445218
{6445218:X4EJ7RFI}
apa
50
1
165299
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
